LRPPRC (leucine-rich pentatricopeptide repeat-containing) has been shown to be essential for the maturation of COX (cytochrome c oxidase), possibly by stabilizing RNA transcripts of COXI, COXII and COXIII genes encoded in mtDNA (mitochondrial DNA). We established a mouse 'gene-trap' model using ES cells (embryonic stem cells) in which the C-terminus of LRPPRC has been replaced with a β-geo construct. Mice homozygous for this modification were found to be subject to embryonic lethality, with death before 12.5 dpc (days post-coitum). Biochemical analysis of MEFs (mouse embryonic fibroblasts) isolated from homozygous mutants showed a major decrease in COX activity, with slight reductions in other respiratory chain complexes with mtDNA encoded components. Constructs of LRPPRC containing different numbers of PPRs (pentatricopeptide repeats) were expressed as recombinant proteins and tested for their ability to bind to the COXI mRNA transcript. Full binding required the first 19 PPR motifs. A specific segment of COXI mRNA was identified as the binding target for LRPPRC, encoded by mouse mtDNA nucleotides 5961-6020. These data strongly suggest that LRPPRC is involved in the maturation of COX, and is involved in stabilizing of mitochondrial mRNAs encoding COX transcripts.
INTRODUCTION
Mutations in nuclear genes are widely associated with defects in respiratory chain construction and assembly. CIV (complex IV) deficiency has been associated with stop mutations and missense mutations in the nuclear subunits and assembly factors necessary for the expression of this complex in mitochondria. Mutations in SURF1, SCO1, SCO2 and COX10 have been found to result in COX (cytochrome c oxidase) deficiency and their functions relate to subunit assembly, copper delivery and haem A synthesis [1] . A founder mutation in the LRPPRC (leucinerich pentatricopeptide repeat-containing) gene was shown to be responsible for a geographically discrete form of COX deficiency in the Saguenay region of Quebec [LSFC (Leigh Syndrome French Canadian), OMIM No. 220111]. The LRPPRC protein is a distant mammalian homologue of the yeast protein PET309, a PPR (pentatricopeptide repeat) protein required for the efficient expression of COX [2] [3] [4] .
In 2000, Small and Peeters [5] described a set of proteins with 35 amino acid repeat sequences that were dubbed 'pentatricopeptide repeat cassette proteins'. LRPPRC protein contains 20 PPR motifs. The PPR motif is predicted to consist of two α-helices with the helix pairs packing together to form a groove, on the basis of an alignment of 1000 putative motifs (Pfam PF01535) [5, 6] . Although initially predicted to bind protein, it has now become evident that PPR proteins are RNA-binding proteins with a certain degree of specificity. These PPR repeats which occur in variable numbers (average 9.1 per protein) are present in many proteins, the majority of which are organellar proteins present in mitochondria or chloroplasts. These include the Saccharomyces cerevisiae protein PET309, the Neurospora crassa protein cya5 and the plant protein CRP1p, all of which were known to be involved in the assembly of chloroplast cytochrome b 6 f or its counterpart in mitochondria, COX [7] [8] [9] . In plants, there are as many as 450 proteins containing PPR motifs that have been shown to play roles in the transcription, splicing, cutting and editing of RNA transcripts in mitochondria and chloroplasts. The proteins play no roles in the nucleus. There are only seven PPR proteins encoded in the human genome: PTCD1, PTCD2, PTCD3, LRPPRC, MRPS27, POLRMT (an RNA polymerase) and MRPP3 (a mito-ribonuclease). This suggests a massive convergence of the roles of PPR proteins in mammals. Plants have a greater need for organellar RNA transcript processing as they have chloroplasts as well as mitochondria, and because their RNA contains introns and has other editing needs not relevant in mammals.
Other roles for LRPPRC have been proposed to include a role in the binding of nuclear-derived mRNA outside of the nuclear envelope, nucleocytosolic shuttling of RNA and chromosome remodelling [10, 11] . That PPR proteins do bind RNA is shown by cross-linking experiments, both with nuclear and with mitochondrial RNA transcripts [12] , a fact that was also suggested by the presence of PPR-binding motifs in mitochondrial RNA polymerase [13] . Indeed, it has been shown that the PPR proteins present in the mitochondria of Trypanosoma brucei have a functional role in mitochondrial ribosomes [14] . A novel role for PPR proteins was also suggested by the observation that the protein CRR4 (chlororespiratory reduction 4) 
in chloroplasts has
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been demonstrated to be involved in editing RNA transcripts in the ndhD (NADH-plastoquinone oxidoreductase subunit 4) initiation codon (ACG-AUG) [15] . There is no evidence that mtDNA (mitochondrial DNA) encoded transcripts are edited, which precludes the same role in animals as is seen in plants; the role in animals is probably more one of RNA protection, involvement in translation or guidance to ribosomal geographical locations [13, 16] . A single missense founder mutation (p.A354V) in LRPPRC has been found in COX-deficient patients with LSFC. This was shown to restrict the import of LRPPRC into mitochondria, resulting in low levels of LRPPRC. As a consequence, decreased levels of mitochondrial mRNA transcripts, particularly those for MT-COXI, MT-COXII and MT-COXIII, were observed [4, 17] . Interaction with the RNA stem-loop-binding protein SLIRP (stem-loop-interacting RNA-binding protein) suggested that LRPPRC was involved in pre-translational events at the mitochondrial ribosome, and additional effects on mtDNA transcripts have been postulated with siRNA (small interfering RNA) suppression of LRPPRC expression [17] .
To further delineate the possible function of LRPPRC in vivo, we established a mouse model using an ES cell (embryonic stem cell) line with an LRPPRC C-terminal replacement mutation containing a selectable marker. In the present study, we followed mouse development and assayed COX activity in embryonic fibroblasts. The biochemical results demonstrate more severe biochemical findings than seen in LSFC patients, in that the homozygous mice exhibit embryonic lethality. Further studies using recombinantly expressed LRPPRC protein indicated a segment of MT-COXI that showed specific binding, although it is likely that LRPPRC PPR motifs also confer more general MT-COXI-binding activity.
MATERIALS AND METHODS

ES cells and gene-trap insertion site identification
A 'gene-trap' ES cell line (AX0080) with a C-terminal replacement mutation of LRPPRC was obtained from the MMRRC (Mutant Mouse Regional Centre) at University of California, Davis, Davis, CA, U.S.A. [18] . The insertion site was first analysed by Southern blotting. Briefly, genomic DNA was prepared from the ES cells by proteinase K digestion, phenol extraction and ethanol precipitation. Purified DNA was cut by EcoRI, BstXI and XbaI and resolved through a 1% agarose gel. After transfer on to a nylon filter, the fragmented DNA was hybridized with a 33 P-labelled probe by PCR using the primers 5 -TGCATGAGTATCCACATGAGT-3 and 5 -GTGCAAACTGATTCGCCATTCTCT-3 . Signals on the filter were revealed by exposure to X-ray film at − 80
• C overnight. On the basis of the fragment size detected by Southern blotting, the insertion location was amplified by PCR using the primers 5 -CCCGTCACTGATCTATTCCTG-3 and 5 -CTGGTCACTTCGATGGTTTGC-3 . The amplified PCR fragment was sequenced and aligned with intron 34 and the genetrap vector respectively. The break-site of the alignments was defined as the insertion site.
Mouse generation and maintenance
The AX0080 ES cells from a C57BL/6 background were injected into blastocysts of 129/J mice. Embryos were transferred into pseudo-pregnant mice. The coloured chimaeras that resulted were mated back to C57BL/6. The genotype was identified by PCR using mouse tail genomic DNA as a template. All procedures met the requirements of the Provincial statute, the Animals for Research Act as well as the Guidelines and Policies of the Canadian Council on Animal Care and were approved by the Toronto Centre for Phenogenomics Animal Care Committee.
Embryonic cell [MEF (mouse embryonic fibroblast)] preparation
Pregnant mice were killed by cervical dislocation and immersed in 75 % ethanol for 30 s. Uterine horns were dissected and placed in tissue culture dishes containing PBS. After removing surrounding tissues, embryos were minced into small pieces and digested in 0.25 % trypsin-EDTA solution plus DNase at a final concentration of 100 units/ml at 37
• C for 15 min with constant shaking. After digesting, the cells were washed once in DMEM (Dulbecco's modified Eagle's medium) with glucose (4.5 g/l), glutamine (2.5 mM), penicillin (100 μg/ml) and streptomycin (100 μg/ml) by centrifugation at 100 g for 5 min. The pellet was collected and resuspended in the same medium. The suspended cells were cultured in the same medium in 5 % CO 2 at 37
• C and grown to confluence. MEFs were immortalized by transfection of a plasmid containing the SV40 (simian virus 40) large T-antigen construct [19] .
Antibodies and Western blotting
Antibodies against mouse LRPPRC and CI (complex I) 49 kDa (NDUSF2) were raised with their C-terminal 14 peptides by immunizing rabbits. An antibody to β-galactosidase antibody was purchased from Invitrogen. Antibodies against CV (complex V) δ subunit, CIV COXI, CIII (complex III) Core I (UQCRC1) and CI ASHI (NDUFB8) subunit were obtained from Mitosciences. CS (citrate synthase) antibody and antibodies against COXII, COXIV, COXVIC were prepared by immunizing rabbits against the purified CS or holoCOX (oxheart COX). Anti-human PTCD3 antibody were prepared by immunizing a rabbit with a peptide corresponding to the 19 amino acids in the centre of the protein (exon 9). Anti-mouse PTCD1 and anti-mouse LRPPRC antibodies were prepared in the same way. Anti-PGC1α (peroxisome-proliferator-activated receptor γ co-activator 1α) and anti-MRPS27 antibodies were from Abcam. Whole-cell lysate was prepared in 1 % Triton X-100 lysis buffer (50 mM Tris/HCl, pH 8.0, 100 mM NaCl, 50 mM KCI and 1 mM EDTA plus a cocktail of proteinase inhibitors) with a brief sonication. The sonicated cell lysate was kept on ice for 15 min and then centrifuged at 16 000 g for 10 min at 4
• C. The supernatant was collected and the protein concentration was measured. Then 50 μg of protein was loaded on each lane and resolved by gradient SDS/PAGE (4-20 % gel). After transferring on to a PVDF filter, the filter was blotted with primary antibody and immunoreactive proteins were visualized using HRP (horseradish peroxidase)-conjugated secondary antibody and Western Lightning Chemiluminescence Reagent Plus (PerkinElmer Life and Analytical Sciences).
Histochemical colour staining of mouse embryos
Embryos were fixed in 2 % formaldehyde in PBS at 4
• C overnight and washed three times in washing buffer [100 mM phosphate buffer, pH 7.2, with 0.01 % NP40 (Nonidet P40)] at room temperature (23 • C) for 20 min each time with constant rocking. The staining for COX was developed in a buffer of 100 mM phosphate buffer, pH 7.2, 100 mM horse heart cytochrome c, 4 mM DAB (3,3 -diaminobenzidine), 5000 units/ml catalase and 0.01 % NP40 at 37
• C for 2 h in the dark. The β-galactosidase staining was developed in 100 mM phosphate buffer, pH 7.2, 2 mM MgCl 2 , 5 mM K 3 Fe(CN) 6 , 5 mM K 4 Fe(CN) 6 , 0.01% DOC (sodium deoxycholate), 0.02 % NP40 and 1 mg/ml Xgal at 37
• C for 2 h in the dark. The staining for SDH (succinate dehydrogenase) was developed in 100 mM phosphate buffer, pH 7.6, 5 mM EDTA, 1 mM KCN, 0.2 mM phenazine methosulfate, 50 mM succinic acid and 1.5 mM NBT (Nitro Blue Tetrazolium) at 37
• C for more than 3 h in the dark.
Biochemical assays of enzymatic activity
NADH:cytochrome c reductase (CI + CIII), and CS activity were measured as described in [20] . SCR (succinate cytochrome c reductase) (CII + CIII) and COX (CIV) were measured as described previously [21] . CV was measured as described previously [22] . Adenine levels were measured as described by Williamson and Corkey [23] .
Blue native gel and in-gel activity assay
Mitochondria were isolated from mouse embryonic cells. Then 50 μg of mitochondrial pellet was suspended in 100 μl of ice-cold solubilizing buffer (50 mM Bis-Tris, pH 7.0, 750 mM aminocaproic acid, 1 mM EDTA and 1.5 g/ml dodecyl maltoside), vortex-mixed and incubated on ice for 30 min. The lysate was cleared by centrifugation at 16 000 g at 4
• C for 10 min. The supernatant was transferred into a fresh tube and the volume adjusted to 110 μl by adding 50 % glycerol. Then 25 μl aliquots of this lysate were loaded into each well and separated on a 4-12 % gradient polyacrylamide gel with a constant voltage of 200 V at 4
• C overnight. The anode buffer was 50 mM Bis-Tris, pH 7.0 and the cathode buffer was 50 mM Tricine and 15 mM Bis-Tris, pH 7.0. The gel was prepared in a buffer of 0.5 M 6-aminocaproic acid and 15 mM Bis-Tris, pH 7.0. Following electrophoresis, the gel was cut into four strips. One strip was stained with Coomassie Blue to show loading. The second one was incubated in CI buffer (5 mM Tris/HCl, pH 7.4, 0.1 mg/ml NADH and 2.5 mg/ml NBT). The third strip was incubated in CIV buffer (50 mM sodium phosphate, pH 7.2, 50 μM horse heart cytochrome c and 0.05 % DAB) and the last one was incubated in CV buffer [35 mM Tris/HCl, 270 mM glycine, pH 8.3, 14 mM MgSO 4 , 0.2% Pb(NO 3 ) 2 and 8 mM ATP]. All of the incubations were performed at room temperature for 3 h and shielded from light. Reactions were terminated by washing three times in PBS and their images were scanned.
RNA preparation and Northern blotting
Total RNA was prepared from whole embryo cells using TRIzol ® reagent (Invitrogen). The RNA quantity was determined by a UV spectrometer. Then 20 μg of total RNA was heated in loading buffer and separated on a 1 % formaldehyde-agarose gel. The purified RNA was transferred on to Hybond-N nylon filter and the filter was hybridized with 33 P-labelled probes. The used filter was stripped in 1 % SDS at 70
• C for 2 h and then processed for the next round of hybridization. All probes were labelled by PCR. • C in 5% CO 2 for another 1 h. The labelled mitochondria were isolated and suspended in 100 μl PBS. Then 4 μl was used to detect the labelling efficiency using a scintillation counter, and then 10 5 c.p.m. of mitochondria were boiled in 20 μl of SDS gel loading buffer and separated on a 10-20 % gradient gel. The resolved proteins were transferred on to a PVDF filter, dried and exposed to X-ray film.
PPR domain constructs and HIS fusion protein purification
PPR domain constructs were truncated from full-length wildtype LRPPRC by PCR (Uniprot accession number Q6PB66). All constructs were N-terminal tagged with His 6 and cloned into pET28 vector. Expression was induced in BL21 cells using IPTG (isopropyl β-D-thiogalactoside) at concentration of 0.1 mM at 37
• C for 3 h. Proteins were purified using HisPur TM Cobalt Resin (Pierce) according to the manufacturer's instructions. Purified proteins were dialysed in PBS with 5 % glycerol at 40
• C for 48 h and frozen at − 80
• C.
RNA gel-shift assay
MT-COXI DNA (GenBank ® accession number NC_010339.1) was amplified by PCR from mouse genomic DNA and cloned into pCR2.1-TOPO TA vector. The vector was linearized and purified. The RNA probe was generated by in vitro transcription with [ 33 P]CTP using SP6 RNA polymerase at 37 • C overnight. Template DNA was digested by adding 10 units of DNase and incubated for 30 min. This radiolabelled probe was purified using RNeasy Mini Kit (Qiagen). Labelling efficiency was determined by liquid scintillation counting. Then 10 5 c.p.m. of probe was used in each reaction with 2-5 μg of purified fusion protein in a volume of 20 μl of binding buffer [20 mM Hepes/KOH, pH 7.5, 50 mM KCI, 4 mM MgCl 2 , 5% glycerol, 10 μg/ml heparin, 0.1 mM EDTA, 1 mM DTT (dithiothreitol), 0.01 % Triton X-100 and 20 units/ml RNaseOUT (Invitrogen)] on ice for 20 min. The unprotected part of RNA was digested at room temperature for 30 min by adding 2 μl of RNase T1 (5-10 units) and mixed well by lightly tapping the tube. The RNA-protein binding complex was separated on 4.5 % polyacrylamide gel (acrylamid/bisacrylamide ratio = 80:1) prepared in 1× TBE (45 mM Tris/borate and 1 mM EDTA) with 5 % glycerol. Electrophoresis was carried out at 4
• C using 0.5× TBE as the running buffer. The gel was dried and exposed to X-ray film.
Oligonucleotide DNA array and hybridization with MT-COXI RNA Oligonucleotide DNA in lengths of 60 nt corresponding to sections of mouse MT-COXI complementary strand were ordered from Integrated DNA Technologies and dissolved at a concentration of 100 nM with dot blot solution (0.4 M NaOH and 10 mM EDTA). Positive nylon filters were wetted in water for 15 min, soaked in dot blot solution for 30 min and then mounted on the dot blot apparatus. Then 80 μl aliquots of sample were loaded into each well, left for 10 min and then vacuum was applied slowly and gradually. After releasing the vacuum, the filter was removed, left at room temperature for 10 min, soaked in 2× SSC (1× SSC is 0.15 M NaCl and 0.015 sodium citrate) for 5 min and then dried at 80
• C for 1 h. The RNA probe was prepared from an RNA-shift gel. Briefly, the LRPPRC-MT-COXI protein-RNA complex was cut from the gel and extracted in 500 μl of TE buffer plus 400 units of RNaseOUT. Following vigorous shaking at 4
• C for 1 h, the gel was filtered through a DNA Miniprep column by centrifugation. The probe in the filtered solution was concentrated, denatured and hybridized with the oligonucleotide DNA filter.
UV cross-linking
LRPPRC (5 μg) was incubated with 2 μg of 5 biotinylated RNA oligonucleotide (50 nt in length) in 15 μl 1× gel-shift binding buffer on ice for 20 min. The reaction was exposed to UV light at 253.7 nm at 4
• C for 10 min and then at 375 nm for another 10 min. After UV exposure, 5 μl of 4× SDS loading buffer was added and heated at 85
• C for 10 min. The cross-linked sample was separated by SDS/PAGE, transferred on to a PVDF filter and blotted with streptavidin-HRP. Following stripping, the filter was re-blotted with anti-LRPPRC antibody. The DNA sequences for the three oligonucleotides are: mMito 8088F, 5 -\ Bios \ CAAACAAATAATGCTAATCCACA-CACCAAAAGGACGAACATGAACCCTAA-3 ; mCoxI 5301, 5 -\ Bios \ TCTAATGCTTACTCAGCCATTTTACCTATGTTC-ATTAATCGTTGATTATTCT-3 ; and mCoxI 5951, 5 -\ Bios \ ACTACTAACAGACCGCAACCTAAACACAACTTTCTTTG-ATCCCGCTGGAG-3
RNA immunoprecipitation
In total, 2×10 7 fibroblast cells were suspended in 1.5 ml of lysis buffer (10 mM Hepes/KOH, pH 8.0, 10 mM NaCl, 1 % NP40, proteinase inhibitors and RNase inhibitor 40 units/ml), sonicated briefly (5 s pulse, twice) and then incubated on ice with frequent vortex-mixing for 30 min. The lysate was collected by centrifugation at 16 000 g for 10 min at 4
• C. In total, 0.5 ml of lysate was removed and used as an input control to extract RNA for COXI PCR. The remaining 1 ml of lysate was added to 9 ml of low concentration detergent lysis buffer (0.2 % NP40, other components as above) and 200 μl 50% suspension of Protein A and G beads and rocked at 4
• C for 1 h. After removing the nonspecific-binding proteins from the beads by centrifugation, half of the lysate was added to 2 μl of pre-immune serum as IgG control and the other half was added to 2 μl of anti-LRPPRC antibody and rocked at 4
• C for 1 h. Following this, 50 μl of fresh Protein A and G beads in 50 % suspension was added and rocked for another 1 h. The RNA-LRPPRC immunocomplexes on the beads were spun down and washed three times and any possible contaminated DNA was removed by adding 3 μl of DNaseI (RNase-free) in 200 μl of volume and incubating at 37
• C for 30 min. RNA in the immunocomplexes was extracted by adding 600 μl of TRIzol ® solution (Invitrogen), vortex-mixing and incubating at room temperature for 5 min and then adding 160 μl of chloroform, vortex-mixing and spinning. The RNA in the supernatant was collected and precipitated with an equal volume of propan-2-ol. After washing once with 70 % ethanol, the sample was dried and re-dissolved in 11 μl of DEPC [diethyl pyrocarbonate] water. Reverse transcription was performed by adding 1 μl of mixed primers [150 ng of oligonucleotide(dT) 18 and 150 ng of random primers] and 1 μl of 10 mM dNTP mixture, heating at 65
• C for 10 min, incubating on ice for 5 min and then adding 4 μl 5× first-strand buffer, 1 μl of 0.1 M DTT, 1 μl of RNaseOUT (40 units) and 1 μl of of SuperScript III reverse transcriptase (200 units) (Invitrogen). The reaction was performed on a PCR machine for one cycle (25 • C for 15 min, 50
• C for 2 h, 55
• C for 2 h, 70
• C for 15 min and then kept at 4 • C till use). Then 3 μl of a cDNA solution was used to PCR-amplify COXI in a 50 μl reaction volume. Then 15 μl of PCR products after 32 cycles of amplification was separated on a 2.5 % agarose gel, stained with ethidium bromide and visualized under a UV light. 
RESULTS
Localization of 'β-geo' insertion within LRPPRC gene-trap ES cell line
We created a mouse model of LSFC, using a gene-trap vector ES cell line, generated by randomly inserting a β-geo selection/reporter construct (cloned in pGT01xr vector) within one copy of the target endogenous gene ( Figure 1A ). In the mouse ES cell line AX0080, the β-geo construct is inserted within intron 34 of LRPPRC. The construct encodes a fusion transcript of lacZ (encoding β-galactosidase) and neo (encoding neomycin phosphotransferase II). The 'β-geo' construct consists of a splice acceptor sequence preceding the β-geo sequence, and a polyadenylation sequence after it. Thus insertion of the vector within a gene creates a mutant gene that may be expressed as a mutant protein in the ES cell line.
We confirmed experimentally the exact site of insertion at the genomic level. By designing a series of PCR primers linking sequence in the 'β-geo' construct to the LRPPRC gene, we successfully identified a 4 kb genomic fragment from the wildtype DNA and a specific 4.7 kb fragment from the mutant LRPPRC (in heterozygotes) in EcoRI, XbaI and BstXI digests ( Figure 1B) . Based on the fragment size of the BstXI digest products in heterozygotes and wild-type, we estimated the insertion site to be 1 kb upstream of exon 35. We designed PCR primers specific for the mutant and wild-type genomic sequence and used these to confirm the location of the insertion site and to screen offspring for mutant status.
Homozygous LRPPRC-β-geo mutant mice show retarded development and embryos are resorbed at the somite stage AX0080 ES cells from the C57BL/6 background were injected into blastocysts of a 129/J mouse. Embryos were transferred into pseudo-pregnant mice. The coloured chimeras that resulted were mated back to C57BL/6. The genotype was identified by PCR using mouse tail genomic DNA as a template. All live mice progeny were either wild-type or heterozygous with no homozygous mutants produced. Heterozygous mice were healthy and fertile. By genotyping mice back from birth to embryos, we found that the homozygous mutants developed abnormally from 10.5 to 12.5 dpc (days post coitum) ( Table 1) . These embryos were retarded in growth, looked small, solid and bluish, and all were dead by 12.5 dpc. Figure 2(A) shows the mutated mouse embryos at 12.5 dpc in utero. The bigger and brighter embryonic masses were healthy individuals and their genotypes were either wild-type or heterozygous. β-Galactosidase histochemical staining of whole embryos confirmed that the small embryos were homozygous mutants ( Figures 2B and 2C) . The wild-type embryos remained white, indicating that the LRPPRC-β-geo fusion protein had viable β-galactosidase activity.
Mutant mice show loss of expression of wild-type LRPPRC and a gain of β-galactosidase activity
The LRPPRC-β-geo fusion protein has a single open reading frame, with the C-terminal 120 amino acids (1272-1392) replaced with β-galactosidase. This genotype should generate a phenotype representing loss of expression of wild-type full-length LRPPRC. We performed Western blotting with antibodies recognizing wild-type LRPPRC and β-galactosidase. This showed that wildtype full-length LRPPRC was present in the wild-type and the LRPPRC-β-geo fusion protein was present only in the lanes of − / − mutants ( Figure 2D ). Blotting with antibody against mitochondrial CI 49 kDa (NDUFS2) subunit showed equivalent loading in all lanes.
CIV enzyme activity is more severely decreased than CI and V activities in mutant mice
Since the p.A354V missense mutation in human LSFC patients produces a mild deficiency of COX activity in skin fibroblasts, we asked whether this LRPPRC-β-geo mutant mouse also exhibited the same defect. Staining of whole embryos for COX activity showed that homozygous mutants turned light yellow ( Figure 2C ), whereas wild-type and heterozygotes appeared reddish brown. The light yellow colour is an indicator that the COX activity is significantly reduced. On re-staining these embryos for β-galactosidase activity with X-gal as substrate, the homozygous mutants turned dark blue, heterozygotes turned light blue and no colour change was found in wild-type littermates. This means only embryos bearing a mutant allele have β-galactosidase activity. A separate litter of embryos was stained for SDH using NBT, and all genotypes of embryos exhibited a dark blue colour, suggesting that there is no effect on SDH. MEFs were established from 8-day embryos deemed to be homozygous by phenotype. This was confirmed by molecular analysis. Biochemical assay of COX in cultured MEFs showed that the activity of CIV was decreased by more than 60 %, with small but significant decreases in CI + CIII (NADH-cytochrome c reductase) and CV (ATPase) ( Figure 2E ). In-gel activities of the native complexes was monitored for CI, CIV and CV and it is apparent that only CIV is lacking in activity ( Figure 2F ).
The cellular adenine nucleotide levels were determined in wildtype and mutant LRPPRC MEFs, and compared with human fibroblasts to see if there were differences that could account for the embryonic lethality of the mutant ( Table 2) . The values for ATP and ATP/ADP ratios were lower in the LRPPRC mutant MEFs but the overall energy charge was within the normal range (0.8-1.0).
Mutant mice have lower COXI protein and RNA levels
Western blotting was carried out using antibodies against the COXI subunit of CIV, and a holo-CIV antibody; ASHI (NDUFB8) subunit of CI; core I subunit of CIII and δ-subunit of CV. We found that COXI was significantly decreased as well as levels of COXII, COXIV and COXVIC ( Figure 3A) .
Northern blotting using probes for MT-COXI, MT-COXII, MT-COXIII, MT-ND2, MT-CYTB and MT-ATP6
, showed that the COXI and COXIII levels were significantly lower, ATP6 was slightly lower, CYTB was slightly higher, and there was no change in ND2 and COXII ( Figure 3B ).
SLIRP is down-regulated whereas PTCD2, MRPS27 and PGC1α are up-regulated in mutant mice
We examined the protein levels of a number of the other mammalian PPR proteins: PTCD1, PTCD2, PTCD3 and MRPS27. We found PTCD2 and MRSP27 were up-regulated ( Figure 3A) . We also looked at proteins that have roles in protein regulation, SLIRP and PGC1α. We found SLIRP was down-regulated whereas PGC1α was up-regulated ( Figure 3A) .
Translation of mitochondrially encoded proteins using [ 35 S]methionine pulse labelling
Since some aspects of the results on enzymatic activity assay in mouse embryonic cells did not match our previous finding that only CIV was affected with no reduction in CI and CV in human fibroblasts [4] , we performed [
35 S]methionine pulse labelling to reveal differences in mitochondrial protein transient state. Mitochondria were isolated after incubation with emetine to inhibit nuclear gene expression, and we found differences based on band intensities of COXI and to a lesser extent COXII and III ( Figure 3C ).
LRPPRC protein binds MT-COXI RNA in vitro
As we have observed the COXI transcript levels to be the most down-regulated in both the gene-trap LRPPRC-β-geo and the LSFC p.A354V double mutant cells, we investigated the interaction between the mouse LRPPRC protein and MT-COXI mRNA by gel shift assay. We made a series of LRPPRC cDNA plasmid constructs with truncated PPR domains ( Figure 4A ). The full-length wild-type version of LRPPRC was manipulated by replacing its N-terminal 58 amino acid mitochondrial leader sequence with HIS 6 tag (PPR [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] . This construct was then either N-terminal or C-terminal deleted to achieve the PPR domain structure desired. This set of proteins was expressed in bacteria and purified ( Figure 4A ). The RNA-protein interaction assay was performed by incubating the purified LRPPRC protein with MT-COXI RNA. As the MT-COXI transcript was too large to enter the gel, we utilized a method of RNA footprinting that relied on the digestion of the unprotected part of RNA by RNase T1. Having digested the complex by incubation with RNase T1 we then resolved the resulting complex on agarose gels. We observed slower migrating bands on the gel, which were LRPPRC-MT-COXI protein-RNA complexes ( Figure 4B ). This interaction could be disrupted by pre-incubating the LRPPRC protein with its own antibody.
To define the binding segment of MT-COXI to LRPPRC we used this same labelled RNaseT1-digested RNA probe from the [ 33 P]LRPPRC-MT-COXI complex to hybridize to DNA arrays of complementary (antisense) MT-COXI nucleotides arranged in 60 nt lengths. We found a strong signal with oligonucleotide B6, which represented mouse mtDNA sequence base pairs 5961-6021 ( Figure 4C ).
Removal of PPR domain 20 did not interfere with RNA-binding ability
We next tested the RNA-binding ability of the range of recombinant PPR domain construct proteins to the full-length MT-COXI probe and to the oligonucleotide-B6 probe. We found all N-terminal truncated proteins lost or decreased their RNAbinding ability [ Figure 19 ) was similar to the mutant protein created using the gene-trap vector. Although migrating patterns were different when using the two probes, their binding characteristics were basically the same.
Specificity of oligonucleotide binding by LRPPRC
We used three 5 -biotinylated synthetic oligonucleotides corresponding to mouse mtDNA sequence base pairs 8088-8138, 5301-5250 and 5951-6001 to bind to recombinant full-length LRPPRC followed by UV cross-linking. The samples were separated by SDS/PAGE and the oligonucleotide visualized using streptavidin-HRP. The binding by the 5951-6001 COXI probe RNA was very strong compared with the control ATP6 oligonucleotide or the N-terminal COXI oligonucleotide probe. Immunoprecipitated LRPPRC from skin fibroblasts was shown by PCR amplification to have bound RNA for COXI (Figures 5B-5E ).
DISCUSSION
In the present study, we established a mouse model from a gene-trap ES cell line with a C-terminal mutation in LRPPRC. Observation of embryonic development showed that homozygous mutant mice died between 10.5 and 11.5 dpc. The embryonic lethality in mutant mice originates from the loss of the C-terminal 119 amino acids. Histochemical colour staining of COX showed lower enzyme activity in mutant embryos, whereas higher activity of X-gal and normal SDH activity was observed. Biochemical analysis using MEFs demonstrated 30 % residual COX activity. There was no change in SCR activity with a concomitant 10 % decrease of CS activity. Western blotting indicated a significantly lower quantity of COXI with partially decrease of other COX subunits. Northern blotting revealed that RNA titres of MT-COXI and MT-COXIII were lower but not MT-COXII, MT-CYTB or MT-ATP6. We showed that LRPPRC is indeed involved in the maturation of CIV and the likely function is the stabilization and/or translation of mitochondrial mRNAs, particularly MT-COXI.
A feature of this model is that the mutation is embryonic lethal, even though 30 % of COX residual activity still remains. This demonstrates that COX still partially assembles, at least in MEFs, in the absence of full-length LRPPRC, but is not enough to sustain viability.
Adenine nucleotide levels were determined for wild-type and mutant LRPPRC MEFs to see if a reduction in ATP production could account for the embryonic lethality ( Table 2 ). The results show that, whereas ATP levels are reduced in mutant cells by 30 %, there is a 30-40 % increase in both ADP and AMP levels maintaining the energy charge of the cells. The energy charge of the adenylate pool gives a quantitative estimate of the energy state of the cell, and can vary between 0 and 1 [24, 25] . When ATPgenerating and ATP-utilizing processes are balanced, the energy charge is 0.85. The energy charge for the wild-type cells is 0.96, compared with 0.91 in the mutant cells. The higher value for the MEFs indicate that the cells are actively metabolizing and growing, and the fact that the mutant cells have only a slightly lower energy charge despite their reduction in total ATP content, confirms the benefits of the compensatory increases in ADP and AMP in these cells. It is known that in some tissues, LRPPRC mutation leads to much lower COX activity. If all tissues were available from the mutant mice, no doubt we would find greater differences in ATP and energy charge when COX is low.
LRPPRC has 20 PPR domains, as defined by Pfam [6] . Owing to the difference in clinical severity between the C-terminal replacement mutation in mice and the missense mutation of p.A345V in human LSFC, this suggests that a full complement of PPR domains is absolutely necessary for normal LRPPRC function. Indeed our conclusion that the p.A354V mutation in LSFC is actually a functionally competent protein but is poorly imported into mitochondria has been echoed by previous studies which found that RNAi knockdown of LRPPRC resulted in less CIV in mitochondria [4, 26] .
In the LSFC cells, there is a residual level of COX activity of 50 % due to the p.A354V missense mutation in LRPPRC in the mitochondria. In the gene-trap mutant, there is 25-30 % activity due to the truncated LRPPRC (PPR motif 20 absent) present in the mitochondria of the mouse model gene-trap cells. This absence of the C-terminal region seems to have dire consequences for the viability of the mice in the homozygous state. The functions previously proposed for LRPPRC and yeast homologue PET309 are that it is somehow protective of COX subunit RNA stability and that it also facilitates translation of COX subunit RNA on mitochondrial ribosomes. We have shown in our experiments that LRPPRC can bind to MT-COXI RNA in an RNase T1 protective manner and that a recombinant protein with PPR motifs 1-19 intact is still very effective at this binding. It is possible that despite binding to RNA species as it should, the missing PPR segment leads to increased susceptibility of the bound RNA to degradation by ribonucleases. Secondly, it could be that the final PPR motif is essential for guidance of the COX mRNAs to the mitochondrial ribosomes. Functionally it appears that COXI in particular and, to a lesser extent, COXII and COXIII mRNAs are decreased in both the mouse model and the p.A354V human mutant, suggesting an anti-RNA degradation mechanism is appropriate for both models, yet biochemically they are quite similar. Others have suggested that LRPPRC protects other mtRNA species such as MT-ND1, MT-CYTB and MT-ATP6. Although these results are derived from RNAi knockdown of LRPPRC and quantitative PCR analysis of RNA levels, we can see no evidence for involvement of these entities either by Northern blotting or by significant decreases in respiratory chain complex activity. The RNAi knockdown experiments effectively remove full-length LRPPRC and therefore may differ in overall effects on mRNA levels in mitochondria [17] .
The role of SLIRP
There has not been any thorough investigation of the role of the PPR proteins in relation to mitochondrial insufficiency. In cells lacking mtDNA and thus by definition, mRNA transcripts, there appears to be down-regulation of LRPPRC, PTCD1, PTCD2 and PTCD3 (results not shown). This may be in keeping with the down-regulation of all proteins associated with nucleoid structures, possibly mediated by lower levels of PGC1α in ρ 0 cells (no mtDNA). We have shown in the present study that decreased LRPPRC function leads to an up-regulation of MRPS27 and PTCD2 accompanied by an up-regulation of PGC1α. This is likely a compensatory mechanism that regulates the amount of PPR proteins.
SLIRP was originally isolated using a yeast three-hybrid system with the SRA (steroid receptor RNA activator) STR7 stem-loop RNA as bait [27] . As with many three-and twohybrid isolates, there is some uncertainty as to whether SLIRP, a largely mitochondrial protein, does have any real contact with the cytosolic SRA system. It was later associated with LRPPRC by identification as a co-immunoprecipitating protein, and was shown to be down-regulated in response to LRPPRC siRNA knockdown experiments. In the present study we show in the mouse model MEFs that mutant LRPPRC leads to decreased SLIRP levels in mitochondria.
One possibility is that the STR7 RNA in some way resembles either COXI RNA and that is partly the reason for crossreactivity. However, comparison of RNA sequence showed no significant similarity either in sequence or in stem-loop structures. Knockdown of SLIRP using siRNA resulted in decreased expression of LRPPRC suggesting that these two entities have interdependent functions [28] . They co-immunoprecipitate from mitochondrial extracts, even from mitochondrial ρ 0 cell extracts, a fact that suggests that RNA is not a factor in their mutual binding [17] . Thus the binding to similar or even dissimilar RNA species can only be resolved by further detailed investigation of actual RNA sequences bound to LRPPRC or SLIRP.
Specificity of RNA binding by LRPPRC
Since the results of the present study and those of others [17] suggest that COXI RNA is probably the prime RNA species that c The Authors Journal compilation c 2012 Biochemical Society is bound by LRPPRC, we did a series of experiments to investigate the nature of this binding. We showed that with full-length labelled COXI RNA we could obtain a gel shift with LRPPRC protein and that the RNA sequence remaining bound to LRPPRC after RNase T1 digestion could be identified by dot blot, to the nucleotide region 5961-6021 of mouse mtDNA (corresponding to nucleotides 623-683 of COXI RNA). Investigation of the number of PPR segments required to bind either the full COXI RNA or an RNA oligonucleotide suggested that binding was most effective with full-length LRPPRC, but that removal of N-terminal PPR segments would reduce the formation of protein-RNA complexes. In addition, the specific COXI RNA sequence could be UV crosslinked effectively to LRPPRC. Since 60 nt would be bound by 20 PPR segments of LRPPRC protein, this agrees with studies on other PPR proteins in plants which are thought to bind in a stoichiometry of one PPR motif to one or two RNA nucleotides.
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